Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05272202Phase 1Recruiting
Phase 1, open-label, single-arm trial, sponsored by CHU Brugmann. Primary endpoint: Amplitude of the Event-Related Desynchronization/Synchronization. Started Jan 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05272202.